Bukwang Pharmaceutical Co., Ltd. logo

Bukwang Pharmaceutical Co., Ltd. (003000)

Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM
₩
3,680. 00
-155
-4.0417%
₩
400.09B Market Cap
- P/E Ratio
125% Div Yield
477,323 Volume
0 Eps
₩ 3,835
Previous Close
Add Transaction
Day Range
3,640 3,795
Year Range
3,490 9,890
Want to track 003000 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Bukwang Pharmaceutical Co., Ltd. (003000) Statistics

Valuation metrics

Market Cap 400.09B
Enterprise value 376.66B
Trailing P/E (ttm) 67.18
Forward P/E -
PEG ratio -1.33
Price/Sales (ttm) 1.86
Price/Book (mrq) 1.19
Enterprise Value/Revenue 1.75
Enterprise Value/EBITDA 22.48

Overview

Shares outstanding 98.66M
Float 70.64M
Shares short -
% Held by insiders 0.31%
% Held by institutions 0.02%
Average volume (10 days) 640.2K
Average volume (90 days) 423.49K

Price summary

52-Week low 3,490
52-Week high 9,890
Beta 0.23
50-Day moving average 4,074.22
200-Day moving average 5,107.43

Dividends and splits

Forward annual dividend rate 125
Forward annual dividend yield 0.0243%
Trailing annual dividend rate 125
Trailing annual dividend yield 0.0308%
5-Year annual dividend yield 0.82%
Payout ratio 1.38
Dividend Date 20 Nov 2025
Ex-Dividend Date 4 Nov 2025
Last split factor 1:1
Last split Date 29 Dec 2020

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.04%
Operating margin 0.05%

Operational effectiveness

Return on assets 0.02%
Return on equity 0.03%

Income Statement

Revenue (ttm) 200.71B
Revenue per share (ttm) 2,202.04
Quarterly revenue growth (yoy) 0.35%
Gross profit (ttm) 91.53B
EBITDA 11.85B
Net income to common (ttm) 12.56B
Diluted EPS (ttm) 91.18
Quarterly earnings growth (yoy) 1.53%

Balance Sheet

Total cash (mrq) 216.21B
Total cash per share (mrq) 1,731.14
Total debt (mrq) 80.34B
Total Debt/Equity (mrq) 0.24
Current ratio (mrq) 2.33%
Book value per share (mrq) 3,423.38

Cash Flow

Cash flow statement 21.46B
Levered free cash flow (LFCF) -9.89B